Evidence map›Paper›PMID 36671333›Full record

ArticleAntibiotics (Basel, Switzerland)2023

New Characterization of Multi-Drug Resistance of

Chun-Liu Dong, Rui-Xiang Che, Tong Wu, Qian-Wei Qu, Mo Chen, Si-Di Zheng, Xue-Hui Cai, Gang Wang, Yan-Hua Li

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Antimicrobial Activity of Aurisin A AgainstInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. One health (Amsterdam, Netherlands) · 2025
    Review
  7. Article
  8. Current prevalence and therapeutic strategies for porcineApplied and environmental microbiology · 2025
    Review
  9. Article
  10. Article
  11. Prevalent and Drug-Resistant Phenotypes and Genotypes ofInternational journal of molecular sciences · 2025
    Article
  12. Article
  13. Insights into the Virulence and Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chun-Liu DongCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China.
Rui-Xiang CheCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China.
Tong WuCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China.
Qian-Wei QuCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China.
Mo ChenCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China.
Si-Di ZhengCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China.
Xue-Hui CaiState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150008, China.
Gang WangState Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150008, China.
Yan-Hua LiCollege of Veterinary Medicine, Northeast Agricultural University, Harbin 150038, China.

Funding

China Agriculture Research System of MOF and MARA CARS-35Heilongjiang Provincial Natural Science Foundation of China LH2020C024National Natural Science Foundation of China 32072908National Natural Science Foundation of China 32102726
6 · The paper itself

Abstract

The aim of this study was to investigate the antimicrobial resistance profiles and genotypes of

Indexed as

biofilmdrug resistance genemulti-drug resistanceserotypeStreptococcus suis

Identifiers

PMID36671333
PMCPMC9854593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.